What is RCKT (RCKT) stock price today?

RCKT (RCKT) is currently trading at $3.25, up 1.88% today.

What is RCKT P/E ratio?

RCKT's P/E ratio is -1.69. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is RCKT return on equity (ROE)?

RCKT's return on equity (ROE) is -80.51%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is RCKT's market cap?

RCKT has a market capitalization of $354.88M.

NASDAQ · Biotechnology

RCKT (RCKT) Stock

$3.25 +1.88% NASDAQ: RCKT Healthcare

Valuation

Metric	Value
Price	$3.25
Market Cap	$354.88M
P/E Ratio	-1.69
P/B Ratio	1.34
P/S Ratio	0.00
EPS (TTM)	$-2.01
52-Week High	$5.45
52-Week Low	$2.40
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-80.51%
ROA	-67.58%
ROCE	-82.67%
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Debt/Equity	0.10
Current Ratio	6.43

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$0	$0	$0	$0	$0
Operating Profit	$-167.0M	$-224.0M	$-260.0M	$-273.0M	$-229.0M
Net Profit	$-169.0M	$-222.0M	$-246.0M	$-259.0M	$-223.0M
EPS	$-2.68	$-3.26	$-2.92	$-2.73	$-2.01
Op Margin	—	—	—	—	—

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$497.0M	$552.0M	$566.0M	$528.0M	$330.0M
Total Liabilities	$42.0M	$62.0M	$74.0M	$64.0M	$53.0M
Cash	$233.0M	$141.0M	$56.0M	$164.0M	$78.0M
Borrowings	$23.0M	$23.0M	$25.0M	$25.0M	$25.0M

Latest News

Is Rocket Pharmaceuticals, Inc. (RCKT) Poised for Recovery After Key Gene Therapy Program Milestone? Insider Monkey · Jun 25, 2026 Sector Update: Healthcare Stocks Advance Pre-Bell Friday MT Newswires · Jun 12, 2026 Rocket Pharmaceuticals Closes $180 Million Sale of Pediatric Priority Review Voucher MT Newswires · Jun 12, 2026 Rocket Pharmaceuticals Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $180 Million Business Wire · Jun 12, 2026 Rocket Pharmaceuticals Inc (RCKT) Got Cash. Where’s the Stock Going? Insider Monkey · May 20, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-121.0M	$-178.0M	$-195.0M	$-210.0M	$-190.0M
Investing Cash Flow	$11.0M	$-78.0M	$-115.0M	$126.0M	$103.0M
Financing Cash Flow	$0	$0	$0	$0	$0
Net Cash Flow	$-65.0M	$-92.0M	$-85.0M	$108.0M	$-86.0M
Free Cash Flow	$-129.0M	$-187.0M	$-211.0M	$-216.0M	$-190.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	—
EV / EBITDA	—
FCF Yield	-50.66%
Quick Ratio	6.12
Interest Coverage	-114.50
Return 1Y	-2.38%
Return 3Y	-81.66%
Return 5Y	-91.68%

Ownership

Insiders Held3.10%

Institutions Held89.44%

Institutions Float Held92.30%

Institutional Holder	Shares	Report Date
RTW Investments LP	17,687,772	2026-03-31
Blackrock Inc.	7,834,795	2026-03-31
Citigroup Inc.	5,107,708	2026-03-31
Vanguard Portfolio Management LLC	4,690,215	2026-03-31
State Street Corporation	4,485,989	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ANNX	$5.37	+0.75%	-3.71	$879.83M	0.00%
AURA	$7.06	-1.40%	-4.35	$453.25M	0.00%
AUTLAutolus Therapeutics plc	$1.46	-13.61%	-1.35	—	0.00%
DBVTDBV Technologies S.A.	$15.84	+0.83%	-3.27	$378.92M	0.00%
DSGN	$13.57	+2.80%	-11.56	$847.54M	0.00%

About RCKT

RCKT is led by CEO Gaurav D. Shah, employs 299 people, headquartered in US, publicly traded since 2015.

RCKT stock trades at $3.25 with a market capitalization of $354.88M. The stock is valued at a price-to-earnings (P/E) ratio of -1.69, price-to-book of 1.34, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $2.40 and $5.45, and currently trades 40.4% below its 52-week high.

On profitability, RCKT generates a return on equity (ROE) of -80.51%, return on capital employed of -82.67%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides